← Back to Search

Standard of Care + Vielight RX Plus Treatment for COVID-19 (COVIDLight Trial)

N/A
Waitlist Available
Research Sponsored by Vielight Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights

COVIDLight Trial Summary

This trial will test if the Vielight RX Plus can help speed up recovery for people with COVID-19 and if it can help reduce the severity of the viral infection.

Eligible Conditions
  • COVID-19
  • Coronavirus

COVIDLight Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Time to recovery
Secondary outcome measures
Average number of days with mild respiratory symptoms
Hospitalization rate
Mean number of days with mild COVID-19 related symptoms
+6 more

COVIDLight Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Standard of Care + Vielight RX Plus TreatmentExperimental Treatment1 Intervention
The is group will receive Vielight RX Plus treatment and follow the COVID-19 standard of treatment recommended by Health Canada.
Group II: Standard of CareActive Control1 Intervention
This group will not receive Vielight RX Plus treatment. Instead, they will follow the COVID-19 standard of treatment recommended by Health Canada.

Find a Location

Who is running the clinical trial?

Vielight Inc.Lead Sponsor
4 Previous Clinical Trials
344 Total Patients Enrolled
1 Trials studying COVID-19
36 Patients Enrolled for COVID-19

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Vielight RX Plus for the Treatment of COVID-19 Respiratory Symptoms
2020. "Vielight RX Plus for the Treatment of COVID-19 Respiratory Symptoms". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04418505.
All > Covid
~64 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top